Status:
COMPLETED
eMotiph: E-mental Health Solution for Patients With Schizophrenia
Lead Sponsor:
Grupo Pulso
Collaborating Sponsors:
Hospital de Sant Pau
Nurogames GmbH
Conditions:
Schizophrenia
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Although the main objective of current schizophrenia intervention programs is the reduction of symptoms, its rates are around 36%, and recovery rates are 16.5%. Between 30 and 50% of people with schiz...
Detailed Description
A prospective non-randomised feasibility trial will be performed. People with a diagnosis of treatment-resistant schizophrenia and their informal caregivers will test the digital mental health solutio...
Eligibility Criteria
Inclusion
- Age between 18-55 years old.
- Diagnosis of schizophrenia following the Diagnostic and Statistical Manual of Mental Disorders-5 criteria.
- Meet criteria for treatment-resistant schizophrenia.
- Used to information and communication technology and with the physical capability to use them.
Exclusion
- Meet criteria for remission according to the Remission of Schizophrenia Working Group (Andreasen et al., 2005).
- The presence of delusions mainly related to their therapists or with new technologies.
- Hearing, vision or motor impairment that makes it impossible to operate a smartphone.
- Intellectual Developmental Disability.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05345977
Start Date
June 1 2021
End Date
February 28 2022
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Santa Creu i Sant Pau
Barcelona, Spain, 08025